These cells are often associated with longer progression-free survival (PFS) and overall survival (OS) [44], as they play an immunosurveillance role by recognizing tumor-specific mutant antigens. Although the presence of CD8+ T cells is crucial, they alone are insufficient to induce a sustained antitumor immune response. The gene discussed is CD8A; the disease is neoplasm.